TFF Pharmaceuticals, Inc.

NasdaqCM:TFFP Stock Report

Market Cap: US$7.5m

TFF Pharmaceuticals Future Growth

Future criteria checks 2/6

TFF Pharmaceuticals is forecast to grow earnings and revenue by 46.8% and 67.3% per annum respectively while EPS is expected to grow by 51.6% per annum.

Key information

46.8%

Earnings growth rate

51.6%

EPS growth rate

Pharmaceuticals earnings growth21.1%
Revenue growth rate67.3%
Future return on equityn/a
Analyst coverage

Low

Last updated15 Apr 2024

Recent future growth updates

Recent updates

Can TFF Pharmaceuticals (NASDAQ:TFFP) Afford To Invest In Growth?

Apr 10
Can TFF Pharmaceuticals (NASDAQ:TFFP) Afford To Invest In Growth?

Is TFF Pharmaceuticals (NASDAQ:TFFP) In A Good Position To Deliver On Growth Plans?

Sep 27
Is TFF Pharmaceuticals (NASDAQ:TFFP) In A Good Position To Deliver On Growth Plans?

TFF Pharma: The Potential Is Still Very Much Present

Aug 29

TFF Pharmaceuticals: Q3 Data Is Pivotal In So Many Ways

Aug 09

TFF Pharmaceuticals expands R&D operations with new Austin facility

Jul 14

TFF Pharmaceuticals: A Highly Attractive Basket Of Options

May 23

We Think TFF Pharmaceuticals (NASDAQ:TFFP) Needs To Drive Business Growth Carefully

May 17
We Think TFF Pharmaceuticals (NASDAQ:TFFP) Needs To Drive Business Growth Carefully

Here's Why We're Not Too Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Situation

Jan 06
Here's Why We're Not Too Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Situation

TFF Pharmaceuticals: Upside Catalysts Starting To Show Up Amid Omicron, But Timidly

Dec 02

Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth

Sep 16
Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth

TFF Pharmaceuticals: Cautiously Optimistic

Sep 09

TFF Pharma's Platform Is Highly Relevant In The Battle Against The Pandemic

Jul 27

TFF Pharmaceuticals: Looking Attractive At These Prices

Jun 03

Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth

Mar 30
Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth

Earnings and Revenue Growth Forecasts

NasdaqCM:TFFP - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202612-26N/AN/A1
12/31/20251-31N/AN/A1
12/31/20241-24N/AN/A1
12/31/20231-21-16-16N/A
9/30/20231-24-20-20N/A
6/30/20231-27-25-24N/A
3/31/20230-30-26-24N/A
12/31/20220-32-29-27N/A
9/30/20220-34-32-31N/A
6/30/20220-36-31-30N/A
3/31/20220-32-32-31N/A
12/31/20210-31-30-30N/A
9/30/20210-27-26-25N/A
6/30/20210-23-24-22N/A
3/31/20210-22-21-20N/A
12/31/2020N/A-19-18-17N/A
9/30/2020N/A-41-15-15N/A
6/30/2020N/A-39-14-14N/A
3/31/2020N/A-38-11-11N/A
12/31/2019N/A-37-11-11N/A
9/30/2019N/A-9-8-8N/A
6/30/2019N/A-7-5-5N/A
3/31/2019N/A-7-4-4N/A
12/31/2018N/A-5-2-2N/A
9/30/2018N/A-4-1-1N/A
6/30/2018N/A-3-1-1N/A
3/31/2018N/A000N/A
12/31/2017N/A000N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TFFP is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: TFFP is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: TFFP is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: TFFP's revenue (67.3% per year) is forecast to grow faster than the US market (8% per year).

High Growth Revenue: TFFP's revenue (67.3% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if TFFP's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.